Addiction to drugs such as methamphetamine, anabolic steroids, cocaine, heroin, inhalants, and marijuana is a serious health problem. Testing for drugs of abuse involves assessing urine samples for these drugs and the results play a crucial role detecting substance abuse or monitoring treatment compliance. Today, many workplaces and clinical labs rely on FDA-approved drug test cups for fast and accurate results.
The drug of abuse testing market comprises of the various devices and kits which help in evaluating drug intake. End users of the market include hospitals, government departments, drug rehabilitation centers, pain management centers and drug testing laboratories.
According to the Future Market Insights market report, the major factors driving the growth of drug of abuse testing market globally during the forecast period 2016-2026 are:
- Stringent rules by the government regarding intake of several harmful drugs
- Increase in consumption of alcohol, drug abuse and rise in the incidence of chronic diseases during the forecast period
- Mounting awareness about drug abuse
- Rapid development of technology
- Increased availability of technologically advanced compact portable drug of abuse testing devices
The report identifies the factors that hinder the market's growth over the forecast period as lack of sufficient numbers of skilled technicians and lower accuracy of the devices.
Geographically, North America accounts for a major share of market and is expected to grow with a healthy CAGR over the forecast period. The fastest CAGR is predicted for the Asia Pacific region, due to factors such as increasing consumption of alcohol and drug addiction among the youth.
The report divides the market into three segments: equipment, rapid testing devices and consumables. Equipment includes immunoassay analyzers, chromatography instruments and alcohol breathalysers, while the rapid testing devices segment is further divided into urine testing and oral fluid testing devices. The consumables segment includes assay kits and sample collection cups.
The key market players include Quest Diagnostics, Alere, Inc., Roche Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthcare (Germany), Biomedical Diagnostics, BioMerieux, and Abbott Laboratories.
According to the report, technologically advanced testing device systems and stringent government norms in different countries are expected to create tremendous opportunities for the market growth in the coming years.
For more information on the Drug of Abuse Testing Market Report, 2016-2026 click here.